RenaissanceRe (RNR) Financials

$239.12 +2.12 (+0.89%)

As of 10:25 AM Eastern

Annual Income Statements for RenaissanceRe

This table shows RenaissanceRe's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	409	481	-245	197	712	731	-73	-1,097	2,526	1,835
Consolidated Net Income / (Loss)	542	630	-355	269	950	993	-103	-1,160	3,620	2,961
Net Income / (Loss) Continuing Operations	542	630	-355	269	536	993	-103	-1,160	3,620	2,961
Total Pre-Tax Income	496	630	-328	263	553	996	-114	-1,219	3,110	2,993
Total Revenue	1,479	1,686	2,059	2,028	3,729	5,122	5,230	5,012	9,061	11,601
Net Interest Income / (Expense)	-36	-42	-44	-47	-58	-50	-48	-48	-73	-94
Total Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Interest Expense	36	42	44	47	58	50	48	48	73	94
Long-Term Debt Interest Expense	36	42	44	47	58	50	48	48	73	94
Total Non-Interest Income	1,515	1,728	2,104	2,075	3,788	5,172	5,278	5,060	9,135	11,695
Other Service Charges	13	14	9.42	5.97	4.95	0.21	11	13	-6.15	1.93
Net Realized & Unrealized Capital Gains on Investments	101	310	377	93	444	1,220	73	-1,286	1,670	1,597
Premiums Earned	1,401	1,403	1,718	1,976	3,338	3,952	5,194	6,334	7,471	10,096
Total Non-Interest Expense	982	1,055	2,388	1,765	3,176	4,126	5,344	6,231	5,951	8,608
Property & Liability Insurance Claims	448	531	1,861	1,120	2,097	2,925	3,876	4,339	3,574	5,333
Other Operating Expenses	296	235	19	34	94	97	41	47	128	135
Amortization Expense	239	289	347	433	762	898	1,215	1,569	1,875	2,644
Other Special Charges	-	-	161	178	223	207	212	277	375	497
Income Tax Expense	-46	0.34	26	-6.30	17	2.86	-11	-59	-510	33
Preferred Stock Dividends Declared	22	22	22	30	37	31	33	35	35	35
Net Income / (Loss) Attributable to Noncontrolling Interest	111	127	-132	42	201	231	-63	-99	1,059	1,090
Basic Earnings per Share	$9.36	$11.50	($6.15)	$4.91	$16.32	$15.34	($1.57)	($25.50)	$52.40	$35.31
Weighted Average Basic Shares Outstanding	43.16M	41.31M	39.85M	39.73M	44.15M	50.71M	43.98M	43.72M	52.69M	49.25M
Diluted Earnings per Share	$9.28	$11.43	($6.15)	$4.91	$16.29	$15.31	($1.57)	($25.50)	$52.27	$35.21
Weighted Average Diluted Shares Outstanding	43.16M	41.31M	39.85M	39.73M	44.15M	50.71M	43.98M	43.72M	52.69M	49.25M
Weighted Average Basic & Diluted Shares Outstanding	43.16M	41.31M	39.85M	39.73M	44.15M	50.71M	43.98M	43.72M	52.69M	49.25M
Cash Dividends to Common per Share	$1.20	$1.24	$1.28	-	-	-	-	-	-	$1.56

This table shows RenaissanceRe's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-825	448	564	191	194	1,577	365	495	1,174	-199	161
Consolidated Net Income / (Loss)	-1,189	693	840	375	417	1,989	618	729	1,633	-19	-25
Net Income / (Loss) Continuing Operations	-1,189	693	840	375	417	1,989	618	729	1,633	-19	-25
Total Pre-Tax Income	-1,186	699	869	381	426	1,434	634	708	1,735	-83	-71
Total Revenue	1,274	2,018	2,193	1,853	1,836	3,179	2,576	2,829	3,974	2,223	3,443
Net Interest Income / (Expense)	-12	-12	-12	0.00	0.00	-61	-23	0.00	0.00	-71	-27
Total Interest Income	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Interest Expense	12	12	12	0.00	0.00	61	23	0.00	0.00	71	27
Long-Term Debt Interest Expense	12	12	12	-	-	-	23	-	-	-	27
Total Non-Interest Income	1,287	2,031	2,205	1,853	1,836	3,240	2,599	2,829	3,974	2,293	3,470
Other Service Charges	2.83	7.69	-4.31	3.88	-5.87	0.14	-0.05	0.17	0.68	1.13	0.91
Net Realized & Unrealized Capital Gains on Investments	-483	399	529	64	86	991	156	287	1,390	-235	749
Premiums Earned	1,767	1,624	1,681	1,785	1,756	2,249	2,444	2,541	2,583	2,528	2,721
Total Non-Interest Expense	2,461	1,319	1,324	1,473	1,410	1,745	1,942	2,121	2,239	2,306	3,514
Property & Liability Insurance Claims	1,968	823	801	931	862	980	1,166	1,310	1,374	1,484	2,744
Other Operating Expenses	10	12	13	38	40	36	39	59	50	-13	23
Amortization Expense	418	413	432	423	426	594	631	644	690	678	647
Other Special Charges	65	72	77	80	83	134	106	108	125	157	100
Income Tax Expense	2.81	5.41	29	5.94	9.30	-554	15	-21	102	-64	-46
Preferred Stock Dividends Declared	8.84	8.84	8.84	8.84	8.84	8.84	8.84	8.84	8.84	8.84	8.84
Net Income / (Loss) Attributable to Noncontrolling Interest	-372	236	267	175	214	403	245	225	450	170	-195
Basic Earnings per Share	($19.27)	$10.40	$12.95	$4.10	$3.81	$31.54	$6.96	$9.44	$22.68	($3.77)	$3.29
Weighted Average Basic Shares Outstanding	43.70M	43.72M	43.93M	51.18M	51.17M	52.69M	52.88M	52.16M	51.94M	49.25M	48.65M
Diluted Earnings per Share	($19.27)	$10.40	$12.91	$4.09	$3.80	$31.47	$6.94	$9.41	$22.62	($3.76)	$3.27
Weighted Average Diluted Shares Outstanding	43.70M	43.72M	43.93M	51.18M	51.17M	52.69M	52.88M	52.16M	51.94M	49.25M	48.65M
Weighted Average Basic & Diluted Shares Outstanding	43.70M	43.72M	43.93M	51.18M	51.17M	52.69M	52.88M	52.16M	51.94M	49.25M	48.65M
Cash Dividends to Common per Share	$0.37	-	$0.38	$0.38	-	-	-	-	$0.39	-	$0.40

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-19	-86	940	-254	271	358	122	-665	683	-201
Net Cash From Operating Activities	425	485	1,026	1,222	2,137	1,993	1,235	1,604	1,912	4,165
Net Cash From Continuing Operating Activities	512	322	1,026	1,222	2,137	1,993	1,235	1,604	1,912	4,165
Net Income / (Loss) Continuing Operations	542	630	-355	269	950	993	-103	-1,160	3,620	2,961
Consolidated Net Income / (Loss)	542	630	-355	269	950	993	-103	-1,160	3,620	2,961
Depreciation Expense	18	29	31	0.12	-59	17	-21	-27	-135	258
Non-Cash Adjustments to Reconcile Net Income	73	-147	-154	230	-415	-789	219	1,646	-490	-20
Changes in Operating Assets and Liabilities, net	-208	-27	1,503	723	1,661	1,772	1,140	1,145	-1,083	966
Net Cash From Investing Activities	-339	-165	-122	-2,537	-2,989	-2,305	-816	-3,016	-3,823	-3,061
Net Cash From Continuing Investing Activities	-339	-165	-122	-2,537	-2,989	-2,305	-816	-3,016	-3,823	-3,061
Purchase of Investment Securities	-10,519	-8,470	-10,113	-14,147	-20,306	-17,638	-16,575	-52,789	-67,833	-59,478
Sale and/or Maturity of Investments	10,180	8,121	9,875	11,611	17,325	15,196	15,552	49,773	64,011	56,417
Net Cash From Financing Activities	-94	-401	29	1,066	1,120	665	-302	725	2,589	-1,288
Net Cash From Continuing Financing Activities	-94	-401	29	1,066	1,120	665	-302	725	2,589	-1,288
Issuance of Debt	446	0.00	296	0.00	396	0.00	30	0.00	816	75
Issuance of Common Equity	-	0.00	0.00	250	0.00	1,096	0.00	0.00	1,352	0.00
Repayment of Debt	-	0.00	-250	0.00	0.00	-250	0.00	0.00	-30	-150
Repurchase of Common Equity	-260	-309	-189	0.00	0.00	-63	-1,028	-167	0.00	-667
Payment of Dividends	-76	-74	-74	-83	-96	-99	-101	-100	-110	-116
Other Financing Activities, Net	-203	-18	245	658	820	107	582	992	562	-429
Effect of Exchange Rate Changes	-11	-4.64	8.22	-5.10	2.48	4.49	6.15	22	5.54	-17
Cash Interest Paid	41	54	44	46	53	49	21	46	74	88
Cash Income Taxes Paid	10	-1.12	0.34	0.34	9.75	5.67	-4.26	3.13	27	100

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-194	-9.90	-131	-120	252	682	-271	20	-54	104	-44
Net Cash From Operating Activities	601	733	436	191	772	512	683	1,212	1,490	779	158
Net Cash From Continuing Operating Activities	601	733	436	191	772	512	683	1,212	1,490	779	158
Net Income / (Loss) Continuing Operations	-1,189	693	840	375	417	1,989	618	729	1,633	-19	-25
Consolidated Net Income / (Loss)	-1,189	693	840	375	417	1,989	618	729	1,633	-19	-25
Depreciation Expense	-11	-26	-33	-40	-48	-14	16	9.96	226	6.85	3.74
Non-Cash Adjustments to Reconcile Net Income	589	-178	-262	155	253	-637	165	139	-843	519	-190
Changes in Operating Assets and Liabilities, net	1,212	243	-110	-299	150	-825	-116	335	475	272	369
Net Cash From Investing Activities	-826	-1,234	-685	-2,497	-328	-314	-304	-979	-1,497	-280	-499
Net Cash From Continuing Investing Activities	-826	-1,234	-685	-2,497	-328	-314	-304	-979	-1,497	-280	-499
Purchase of Investment Securities	-8,749	-32,839	-12,631	-16,920	-15,850	-22,432	-14,909	-18,292	-13,906	-12,370	-14,228
Sale and/or Maturity of Investments	7,973	31,267	11,947	14,424	15,522	22,118	14,605	17,313	12,410	12,090	13,729
Net Cash From Financing Activities	19	500	116	2,186	-198	485	-645	-209	-58	-376	290
Net Cash From Continuing Financing Activities	19	500	116	2,186	-198	485	-645	-209	-58	-376	290
Issuance of Debt	-	-	-	-	-1.02	75	-	-	-	-	866
Repayment of Debt	-	-	-30	-	-	-	-75	-	-25	-50	0.00
Repurchase of Common Equity	-25	-	-	-	-	-	-	-	-107	-452	-358
Payment of Dividends	-25	-25	-26	-28	-28	-29	-29	-29	-29	-29	-28
Other Financing Activities, Net	69	525	172	119	-168	438	-540	-146	103	154	-190
Effect of Exchange Rate Changes	13	-9.31	2.07	0.32	5.01	-1.86	-5.21	-3.57	10	-19	7.50

This table presents RenaissanceRe's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	11,555	12,352	15,226	18,676	26,330	30,821	33,960	36,553	49,007	50,708
Cash and Due from Banks	507	421	1,362	1,108	1,379	1,737	1,859	1,194	1,878	1,677
Trading Account Securities	7,309	7,399	7,917	9,299	12,803	15,564	16,144	17,551	24,612	28,108
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Investment Income	40	38	42	51	72	67	56	122	206	238
Unearned Premiums Asset	1,009	1,429	1,838	2,153	6,159	6,644	8,905	10,872	13,550	8,179
Deferred Acquisition Cost	199	335	427	477	664	634	849	1,172	1,751	1,552
Intangible Assets	265	251	243	237	262	250	243	238	775	704
Other Assets	2,226	2,479	3,398	5,350	4,991	5,925	5,903	5,405	6,235	10,250
Total Liabilities & Shareholders' Equity	11,555	12,352	15,226	18,676	26,330	30,821	33,960	36,553	49,007	50,708
Total Liabilities	5,777	6,310	9,538	11,579	17,287	19,872	23,781	26,692	33,451	33,156
Short-Term Debt	391	306	209	380	225	1,133	1,171	494	662	151
Long-Term Debt	960	949	990	991	1,384	1,136	1,168	1,170	1,959	1,887
Claims and Claim Expense	2,767	2,848	5,080	6,076	9,384	10,381	13,295	15,893	20,487	21,303
Unearned Premiums Liability	889	1,232	1,478	1,716	2,531	2,764	3,531	4,559	6,136	5,950
Other Long-Term Liabilities	769	976	1,782	2,416	3,763	4,458	4,616	4,576	4,208	3,864
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	1,046	1,176	1,297	2,052	3,071	3,388	3,554	4,535	6,101	6,978
Total Equity & Noncontrolling Interests	4,732	4,867	4,391	5,045	5,971	7,560	6,624	5,325	9,455	10,574
Total Preferred & Common Equity	4,732	4,867	4,391	5,045	5,971	7,560	6,624	5,325	9,455	10,574
Preferred Stock	400	400	400	650	650	525	750	750	750	750
Total Common Equity	4,332	4,467	3,991	4,395	5,321	7,035	5,874	4,575	8,705	9,824
Common Stock	551	258	77	338	612	1,674	653	519	2,197	1,563
Retained Earnings	3,779	4,208	3,914	4,058	4,711	5,374	5,233	4,071	6,522	8,276
Accumulated Other Comprehensive Income / (Loss)	2.11	1.13	0.22	-1.43	-1.94	-13	-11	-15	-14	-15

This table presents RenaissanceRe's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	35,936	38,270	41,400	40,843	50,944	51,568	52,756	53,633
Cash and Due from Banks	1,204	1,064	944	1,196	1,607	1,627	1,573	1,633
Trading Account Securities	15,957	18,032	19,070	19,352	24,877	26,168	28,731	28,539
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Investment Income	85	122	148	154	197	226	223	217
Unearned Premiums Asset	11,682	11,771	12,367	6,958	9,714	15,081	9,424	14,230
Deferred Acquisition Cost	1,181	1,242	1,301	1,267	1,822	1,816	1,719	1,685
Intangible Assets	239	237	235	234	759	737	717	686
Other Assets	5,587	5,802	7,242	11,683	11,968	5,913	10,369	6,644
Total Liabilities & Shareholders' Equity	35,936	38,270	41,400	40,843	50,944	51,568	52,756	53,633
Total Liabilities	26,879	27,047	28,321	27,592	34,854	35,053	34,653	36,595
Short-Term Debt	590	389	548	812	1,428	778	607	552
Long-Term Debt	1,170	1,141	1,882	1,883	1,884	1,960	1,936	2,754
Claims and Claim Expense	15,663	15,997	16,138	15,955	20,370	20,741	21,221	22,857
Unearned Premiums Liability	5,046	5,251	5,717	5,222	7,248	7,697	7,041	6,999
Other Long-Term Liabilities	4,410	4,270	4,035	3,720	3,924	3,877	3,848	3,433
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	4,175	5,357	5,676	5,662	6,298	6,335	6,861	6,690
Total Equity & Noncontrolling Interests	4,882	5,866	7,403	7,589	9,793	10,179	11,243	10,349
Total Preferred & Common Equity	4,882	5,866	7,403	7,589	9,793	10,179	11,243	10,349
Preferred Stock	750	750	750	750	750	750	750	750
Total Common Equity	4,132	5,116	6,653	6,839	9,043	9,429	10,493	9,599
Common Stock	509	512	1,876	1,888	2,190	2,101	2,011	1,196
Retained Earnings	3,639	4,619	4,790	4,965	6,866	7,341	8,495	8,418
Accumulated Other Comprehensive Income / (Loss)	-17	-15	-14	-15	-14	-13	-13	-15

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.00%	13.99%	22.17%	-1.54%	83.91%	37.33%	2.11%	-4.17%	80.79%	28.03%
EBITDA Growth	-29.96%	28.21%	-145.01%	188.48%	88.18%	104.80%	-113.34%	-822.14%	338.83%	9.29%
EBIT Growth	-27.73%	27.00%	-152.06%	180.02%	110.72%	79.97%	-111.46%	-968.14%	355.17%	-3.76%
NOPAT Growth	-20.99%	16.19%	-136.46%	217.06%	99.38%	85.22%	-108.04%	-968.14%	524.31%	-18.22%
Net Income Growth	-20.99%	16.19%	-156.29%	175.82%	253.37%	4.50%	-110.42%	-1,021.25%	412.13%	-18.22%
EPS Growth	-26.35%	23.17%	-153.81%	179.84%	231.77%	-6.02%	-110.25%	-1,524.20%	304.98%	-32.64%
Operating Cash Flow Growth	-35.67%	14.07%	111.60%	19.10%	74.94%	-6.76%	-38.03%	29.87%	19.20%	117.87%
Free Cash Flow Firm Growth	-266.55%	140.74%	-61.04%	-827.20%	-25.48%	4.58%	139.45%	-77.56%	-2,277.64%	151.05%
Invested Capital Growth	30.83%	2.34%	-5.62%	22.97%	25.79%	24.08%	-5.30%	-7.93%	57.71%	7.77%
Revenue Q/Q Growth	3.68%	-1.37%	7.08%	2.88%	3.88%	32.96%	-14.81%	24.36%	14.70%	-7.62%
EBITDA Q/Q Growth	-14.86%	-7.59%	-14.87%	-45.54%	-33.16%	738.63%	-120.15%	36.51%	33.56%	-31.52%
EBIT Q/Q Growth	-14.86%	-7.45%	-13.93%	-40.16%	-30.63%	897.34%	-117.08%	37.70%	30.98%	-33.64%
NOPAT Q/Q Growth	-14.87%	-5.21%	-13.93%	-31.94%	-31.78%	1,235.78%	-111.29%	37.70%	55.71%	-40.41%
Net Income Q/Q Growth	-14.87%	-5.21%	-33.53%	-31.94%	20.91%	17.97%	48.30%	25.88%	55.71%	-40.41%
EPS Q/Q Growth	-21.22%	-1.64%	-34.87%	-31.14%	20.67%	23.87%	40.53%	18.27%	67.53%	-50.01%
Operating Cash Flow Q/Q Growth	-1.03%	-24.63%	45.27%	-6.93%	33.77%	-9.53%	-15.70%	23.04%	-10.35%	6.83%
Free Cash Flow Firm Q/Q Growth	12.05%	-22.01%	-49.37%	-70.93%	18.26%	44.46%	-71.22%	213.84%	-8.11%	478.48%
Invested Capital Q/Q Growth	-2.21%	-0.89%	1.22%	6.29%	-1.08%	-2.18%	3.76%	6.55%	13.99%	-5.12%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	34.79%	39.13%	-14.42%	12.96%	13.26%	19.77%	-2.58%	-24.86%	32.83%	28.03%
EBIT Margin	33.57%	37.40%	-15.94%	12.95%	14.84%	19.44%	-2.18%	-24.32%	34.32%	25.80%
Profit (Net Income) Margin	36.67%	37.38%	-17.22%	13.26%	25.48%	19.39%	-1.98%	-23.14%	39.95%	25.52%
Tax Burden Percent	109.24%	99.95%	108.07%	102.40%	171.72%	99.71%	90.65%	95.16%	116.40%	98.91%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	-9.24%	0.05%	0.00%	-2.40%	3.11%	0.29%	0.00%	0.00%	-16.40%	1.09%
Return on Invested Capital (ROIC)	8.62%	8.73%	-3.24%	3.50%	5.61%	8.32%	-0.62%	-7.10%	24.38%	15.68%
ROIC Less NNEP Spread (ROIC-NNEP)	8.62%	8.73%	-13.43%	3.50%	33.39%	8.32%	-1.64%	-22.42%	24.38%	15.68%
Return on Net Nonoperating Assets (RNNOA)	1.44%	1.93%	-2.81%	0.70%	6.17%	1.61%	-0.36%	-4.48%	4.11%	2.21%
Return on Equity (ROE)	10.06%	10.66%	-6.05%	4.21%	11.78%	9.93%	-0.98%	-11.58%	28.49%	17.88%
Cash Return on Invested Capital (CROIC)	-18.09%	6.43%	2.55%	-17.10%	-17.23%	-13.17%	4.82%	1.16%	-20.41%	8.19%
Operating Return on Assets (OROA)	5.02%	5.27%	-2.38%	1.55%	2.46%	3.49%	-0.35%	-3.46%	7.27%	6.00%
Return on Assets (ROA)	5.49%	5.27%	-2.57%	1.59%	4.22%	3.48%	-0.32%	-3.29%	8.46%	5.94%
Return on Common Equity (ROCE)	7.28%	7.94%	-4.36%	2.76%	7.09%	6.14%	-0.60%	-6.04%	14.88%	10.01%
Return on Equity Simple (ROE_SIMPLE)	11.46%	12.95%	-8.08%	5.33%	15.91%	13.14%	-1.56%	-21.78%	38.29%	28.00%
Net Operating Profit after Tax (NOPAT)	542	630	-230	269	536	993	-80	-853	3,620	2,961
NOPAT Margin	36.67%	37.38%	-11.15%	13.26%	14.38%	19.39%	-1.53%	-17.02%	39.95%	25.52%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	10.19%	0.00%	-27.78%	0.00%	1.02%	15.32%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	66.43%	62.60%	115.94%	87.05%	85.16%	80.56%	102.18%	124.32%	65.68%	74.20%
Earnings before Interest and Taxes (EBIT)	496	630	-328	263	553	996	-114	-1,219	3,110	2,993
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	515	660	-297	263	494	1,013	-135	-1,246	2,975	3,252
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.06	1.18	1.19	1.17	1.57	1.16	1.30	1.73	1.14	1.32
Price to Tangible Book Value (P/TBV)	1.13	1.25	1.27	1.24	1.65	1.20	1.36	1.83	1.26	1.42
Price to Revenue (P/Rev)	3.11	3.11	2.31	2.53	2.23	1.60	1.46	1.58	1.10	1.11
Price to Earnings (P/E)	11.25	10.92	0.00	26.05	11.70	11.18	0.00	0.00	3.95	7.04
Dividend Yield	1.14%	0.97%	1.08%	1.03%	0.72%	0.87%	0.87%	0.81%	0.78%	0.63%
Earnings Yield	8.89%	9.15%	0.00%	3.84%	8.55%	8.95%	0.00%	0.00%	25.34%	14.20%
Enterprise Value to Invested Capital (EV/IC)	0.97	1.05	0.91	0.96	1.15	0.95	0.99	1.19	0.97	1.07
Enterprise Value to Revenue (EV/Rev)	4.66	4.54	3.05	4.00	3.29	2.46	2.37	2.73	1.94	1.81
Enterprise Value to EBITDA (EV/EBITDA)	13.39	11.61	0.00	30.85	24.84	12.46	0.00	0.00	5.90	6.46
Enterprise Value to EBIT (EV/EBIT)	13.88	12.15	0.00	30.86	22.19	12.67	0.00	0.00	5.65	7.02
Enterprise Value to NOPAT (EV/NOPAT)	12.71	12.16	0.00	30.14	22.90	12.71	0.00	0.00	4.85	7.10
Enterprise Value to Operating Cash Flow (EV/OCF)	16.21	15.80	6.13	6.63	5.75	6.33	10.05	8.54	9.19	5.05
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	16.52	34.81	0.00	0.00	0.00	20.02	98.38	0.00	13.58
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.23	0.21	0.21	0.19	0.18	0.21	0.23	0.17	0.17	0.12
Long-Term Debt to Equity	0.17	0.16	0.17	0.14	0.15	0.10	0.11	0.12	0.13	0.11
Financial Leverage	0.17	0.22	0.21	0.20	0.18	0.19	0.22	0.20	0.17	0.14
Leverage Ratio	1.83	2.02	2.35	2.65	2.79	2.86	3.07	3.52	3.37	3.01
Compound Leverage Factor	1.83	2.02	2.35	2.65	2.79	2.86	3.07	3.52	3.37	3.01
Debt to Total Capital	18.96%	17.19%	17.40%	16.20%	15.11%	17.17%	18.69%	14.44%	14.42%	10.40%
Short-Term Debt to Total Capital	5.49%	4.19%	3.03%	4.49%	2.11%	8.57%	9.35%	4.28%	3.64%	0.77%
Long-Term Debt to Total Capital	13.47%	13.00%	14.37%	11.70%	12.99%	8.60%	9.33%	10.16%	10.78%	9.63%
Preferred Equity to Total Capital	5.61%	5.48%	5.81%	7.68%	6.10%	3.97%	5.99%	6.51%	4.13%	3.83%
Noncontrolling Interests to Total Capital	14.67%	16.11%	18.83%	24.23%	28.83%	25.64%	28.39%	39.35%	33.57%	35.62%
Common Equity to Total Capital	60.76%	61.21%	57.96%	51.90%	49.96%	53.23%	46.93%	39.70%	47.89%	50.15%
Debt to EBITDA	2.63	1.90	-4.04	5.22	3.26	2.24	-17.31	-1.34	0.88	0.63
Net Debt to EBITDA	1.64	1.26	0.55	1.00	0.47	0.53	-3.55	-0.38	0.25	0.11
Long-Term Debt to EBITDA	1.87	1.44	-3.33	3.77	2.80	1.12	-8.65	-0.94	0.66	0.58
Debt to NOPAT	2.49	1.99	-5.22	5.10	3.00	2.28	-29.28	-1.95	0.72	0.69
Net Debt to NOPAT	1.56	1.32	0.71	0.98	0.43	0.54	-6.01	-0.55	0.21	0.12
Long-Term Debt to NOPAT	1.77	1.51	-4.31	3.69	2.58	1.14	-14.63	-1.37	0.54	0.64
Noncontrolling Interest Sharing Ratio	27.63%	25.56%	27.90%	34.40%	39.80%	38.19%	38.90%	47.85%	47.75%	44.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,138	464	181	-1,313	-1,648	-1,572	620	139	-3,031	1,547
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-31.37	11.00	4.09	-27.90	-28.23	-31.16	13.05	2.88	-41.42	16.50
Operating Cash Flow to Interest Expense	11.72	11.50	23.21	25.96	36.62	39.50	25.98	33.18	26.12	44.42
Operating Cash Flow Less CapEx to Interest Expense	11.72	11.50	23.21	25.96	36.62	39.50	25.98	33.18	26.12	44.42
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.15	0.14	0.15	0.12	0.17	0.18	0.16	0.14	0.21	0.23
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,130	7,297	6,886	8,468	10,652	13,217	12,517	11,525	18,176	19,589
Invested Capital Turnover	0.24	0.23	0.29	0.26	0.39	0.43	0.41	0.42	0.61	0.61
Increase / (Decrease) in Invested Capital	1,680	167	-410	1,582	2,184	2,565	-700	-992	6,651	1,413
Enterprise Value (EV)	6,891	7,658	6,285	8,105	12,279	12,620	12,415	13,693	17,559	21,012
Market Capitalization	4,600	5,250	4,751	5,140	8,328	8,175	7,631	7,938	9,966	12,923
Book Value per Share	$98.80	$108.53	$99.71	$109.15	$120.52	$138.46	$127.65	$104.69	$170.11	$189.14
Tangible Book Value per Share	$92.75	$102.43	$93.64	$103.26	$114.58	$133.55	$122.36	$99.25	$154.96	$175.59
Total Capital	7,130	7,297	6,886	8,468	10,652	13,217	12,517	11,525	18,176	19,589
Total Debt	1,352	1,254	1,198	1,371	1,609	2,269	2,339	1,664	2,620	2,037
Total Long-Term Debt	960	949	990	991	1,384	1,136	1,168	1,170	1,959	1,887
Net Debt	845	833	-163	264	230	532	480	470	743	361
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Nonoperating Expense (NNE)	0.00	0.00	125	0.00	-414	0.00	24	307	0.00	0.00
Net Nonoperating Obligations (NNO)	1,352	1,254	1,198	1,371	1,609	2,269	2,339	1,664	2,620	2,037
Total Depreciation and Amortization (D&A)	18	29	31	0.12	-59	17	-21	-27	-135	258
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$9.36	$11.50	($6.15)	$4.91	$16.32	$15.34	($1.57)	($25.50)	$52.40	$35.31
Adjusted Weighted Average Basic Shares Outstanding	43.14M	40.94M	40.02M	42.21M	44.15M	50.71M	43.98M	43.72M	52.69M	49.25M
Adjusted Diluted Earnings per Share	$9.28	$11.43	($6.15)	$4.91	$16.29	$15.31	($1.57)	($25.50)	$52.27	$35.21
Adjusted Weighted Average Diluted Shares Outstanding	43.14M	40.94M	40.02M	42.21M	44.15M	50.71M	43.98M	43.72M	52.69M	49.25M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	43.14M	40.94M	40.02M	42.21M	44.15M	50.71M	43.98M	43.72M	52.69M	49.25M
Normalized Net Operating Profit after Tax (NOPAT)	347	630	-117	309	752	1,199	69	-660	2,440	3,452
Normalized NOPAT Margin	23.50%	37.38%	-5.69%	15.22%	20.16%	23.41%	1.31%	-13.16%	26.92%	29.75%
Pre Tax Income Margin	33.57%	37.40%	-15.94%	12.95%	14.84%	19.44%	-2.18%	-24.32%	34.32%	25.80%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.69	14.96	-7.43	5.58	9.48	19.74	-2.40	-25.22	42.50	31.92
NOPAT to Interest Expense	14.95	14.95	-5.20	5.71	9.19	19.68	-1.68	-17.65	49.47	31.57
EBIT Less CapEx to Interest Expense	13.69	14.96	-7.43	5.58	9.48	19.74	-2.40	-25.22	42.50	31.92
NOPAT Less CapEx to Interest Expense	14.95	14.95	-5.20	5.71	9.19	19.68	-1.68	-17.65	49.47	31.57
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	14.08%	11.74%	-20.79%	30.84%	10.12%	10.01%	-97.37%	-8.63%	3.05%	3.93%
Augmented Payout Ratio	62.01%	60.85%	-73.97%	30.84%	10.12%	16.32%	-1,090.70%	-23.00%	3.05%	26.45%

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.86%	94.73%	153.68%	116.73%	44.07%	57.53%	17.48%	52.63%	116.44%	-30.09%	33.66%
EBITDA Growth	-78.38%	1,656.45%	288.55%	222.30%	131.58%	111.09%	-22.29%	110.83%	418.62%	-105.37%	-110.32%
EBIT Growth	-79.04%	1,906.89%	300.19%	228.07%	135.90%	105.27%	-27.08%	85.90%	307.37%	-105.80%	-111.17%
NOPAT Growth	-79.04%	2,661.29%	376.47%	280.10%	150.17%	186.81%	-26.40%	94.42%	291.97%	-102.93%	-108.01%
Net Income Growth	-86.10%	140.51%	311.40%	240.50%	135.03%	186.81%	-26.40%	94.42%	291.97%	-100.97%	-104.08%
EPS Growth	-97.64%	121.28%	241.87%	154.32%	119.72%	202.60%	-46.24%	130.07%	495.26%	-111.95%	-52.88%
Operating Cash Flow Growth	28.84%	69.35%	159.00%	89.19%	28.46%	-30.10%	56.86%	534.83%	92.91%	51.99%	-76.92%
Free Cash Flow Firm Growth	-57.65%	150.46%	-17.59%	-509.33%	-1,230.49%	-376.60%	-2,565.38%	10.16%	34.89%	68.44%	83.57%
Invested Capital Growth	-10.34%	-7.93%	4.90%	31.67%	47.41%	57.71%	52.14%	24.14%	29.48%	7.77%	4.85%
Revenue Q/Q Growth	49.04%	58.36%	8.66%	-15.49%	-0.93%	73.16%	-19.55%	9.79%	40.49%	-44.06%	54.92%
EBITDA Q/Q Growth	-330.00%	156.23%	24.25%	-59.29%	11.03%	275.85%	-54.26%	10.44%	173.12%	-103.89%	12.10%
EBIT Q/Q Growth	-299.00%	158.91%	24.39%	-56.20%	11.85%	236.84%	-55.81%	11.66%	145.09%	-104.79%	14.85%
NOPAT Q/Q Growth	-299.00%	183.51%	21.20%	-55.40%	11.14%	377.41%	-68.90%	17.81%	124.08%	-103.56%	14.85%
Net Income Q/Q Growth	-345.73%	158.32%	21.20%	-55.40%	11.14%	377.41%	-68.90%	17.81%	124.08%	-101.18%	-31.42%
EPS Q/Q Growth	-155.91%	153.97%	24.13%	-68.32%	-7.09%	728.16%	-77.95%	35.59%	140.38%	-116.62%	186.97%
Operating Cash Flow Q/Q Growth	495.72%	21.93%	-40.57%	-56.17%	304.50%	-33.65%	33.36%	77.38%	22.92%	-47.73%	-79.74%
Free Cash Flow Firm Q/Q Growth	-49.16%	304.42%	-85.49%	-1,471.71%	-40.42%	1.05%	-29.35%	50.01%	-1.76%	52.05%	32.66%
Invested Capital Q/Q Growth	-8.17%	6.55%	10.66%	21.61%	2.81%	13.99%	6.75%	-0.78%	7.24%	-5.12%	3.85%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	-93.92%	33.35%	38.13%	18.37%	20.59%	44.69%	25.22%	25.37%	49.33%	-3.43%	-1.95%
EBIT Margin	-93.07%	34.62%	39.64%	20.54%	23.19%	45.12%	24.60%	25.02%	43.65%	-3.74%	-2.06%
Profit (Net Income) Margin	-93.29%	34.36%	38.32%	20.22%	22.69%	62.55%	24.01%	25.76%	41.09%	-0.86%	-0.73%
Tax Burden Percent	100.24%	99.23%	96.67%	98.44%	97.82%	138.64%	97.57%	102.95%	94.12%	23.12%	35.69%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.77%	3.33%	1.56%	2.18%	-38.64%	2.43%	-2.95%	5.88%	0.00%	0.00%
Return on Invested Capital (ROIC)	-22.95%	14.32%	19.51%	10.88%	13.39%	38.17%	14.10%	15.44%	28.20%	-1.61%	-0.90%
ROIC Less NNEP Spread (ROIC-NNEP)	-42.79%	14.32%	19.51%	10.88%	13.39%	38.17%	14.10%	15.44%	28.20%	0.06%	-0.17%
Return on Net Nonoperating Assets (RNNOA)	-8.03%	2.86%	3.30%	1.93%	2.67%	6.43%	2.50%	2.70%	4.71%	0.01%	-0.03%
Return on Equity (ROE)	-30.98%	17.19%	22.81%	12.81%	16.07%	44.60%	16.60%	18.14%	32.91%	-1.60%	-0.94%
Cash Return on Invested Capital (CROIC)	-1.07%	1.16%	-4.16%	-22.07%	-20.95%	-20.41%	-20.22%	0.05%	1.46%	8.19%	6.92%
Operating Return on Assets (OROA)	-10.80%	4.92%	6.87%	3.94%	4.77%	9.56%	5.21%	5.61%	11.71%	-0.87%	-0.49%
Return on Assets (ROA)	-10.82%	4.88%	6.65%	3.88%	4.67%	13.25%	5.08%	5.77%	11.02%	-0.20%	-0.17%
Return on Common Equity (ROCE)	-16.29%	8.96%	11.22%	6.44%	7.90%	23.30%	8.61%	9.86%	18.19%	-0.90%	-0.53%
Return on Equity Simple (ROE_SIMPLE)	-32.05%	0.00%	1.33%	9.72%	30.64%	0.00%	34.70%	36.86%	44.19%	0.00%	22.39%
Net Operating Profit after Tax (NOPAT)	-830	693	840	375	417	1,989	618	729	1,633	-58	-50
NOPAT Margin	-65.15%	34.36%	38.32%	20.22%	22.69%	62.55%	24.01%	25.76%	41.09%	-2.62%	-1.44%
Net Nonoperating Expense Percent (NNEP)	19.84%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1.67%	-0.73%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	193.07%	65.38%	60.36%	79.46%	76.81%	54.88%	75.40%	74.98%	56.35%	103.74%	102.06%
Earnings before Interest and Taxes (EBIT)	-1,186	699	869	381	426	1,434	634	708	1,735	-83	-71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1,197	673	836	340	378	1,421	650	718	1,960	-76	-67
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.47	1.73	1.70	1.22	1.47	1.14	1.33	1.25	1.35	1.32	1.23
Price to Tangible Book Value (P/TBV)	1.56	1.83	1.78	1.27	1.52	1.26	1.45	1.36	1.45	1.42	1.33
Price to Revenue (P/Rev)	1.50	1.58	1.37	1.11	1.27	1.10	1.27	1.13	1.13	1.11	0.95
Price to Earnings (P/E)	0.00	0.00	0.00	21.53	7.20	3.95	5.16	4.49	3.94	7.04	7.25
Dividend Yield	1.06%	0.81%	0.75%	0.81%	0.77%	0.78%	0.65%	0.69%	0.57%	0.63%	0.65%
Earnings Yield	0.00%	0.00%	0.00%	4.64%	13.89%	25.34%	19.38%	22.26%	25.41%	14.20%	13.80%
Enterprise Value to Invested Capital (EV/IC)	1.07	1.19	1.20	1.03	1.13	0.97	1.07	1.04	1.10	1.07	1.03
Enterprise Value to Revenue (EV/Rev)	2.86	2.73	2.41	2.19	2.27	1.94	2.20	1.92	1.81	1.81	1.68
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	448.82	24.58	8.07	5.90	7.44	6.32	4.80	6.46	8.26
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	180.41	21.05	7.57	5.65	7.22	6.25	5.05	7.02	9.15
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	195.66	22.30	7.73	4.85	6.11	5.33	4.59	7.10	9.04
Enterprise Value to Operating Cash Flow (EV/OCF)	8.85	8.54	8.15	8.18	8.43	9.19	9.61	6.29	5.85	5.05	5.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	98.38	0.00	0.00	0.00	0.00	0.00	2,337.74	85.19	13.58	15.22
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.19	0.17	0.14	0.19	0.20	0.17	0.21	0.17	0.14	0.12	0.19
Long-Term Debt to Equity	0.13	0.12	0.10	0.14	0.14	0.13	0.12	0.12	0.11	0.11	0.16
Financial Leverage	0.19	0.20	0.17	0.18	0.20	0.17	0.18	0.17	0.17	0.14	0.20
Leverage Ratio	3.61	3.52	3.43	3.30	3.44	3.37	3.27	3.14	2.99	3.01	3.16
Compound Leverage Factor	3.61	3.52	3.43	3.30	3.44	3.37	3.27	3.14	2.99	3.01	3.16
Debt to Total Capital	16.27%	14.44%	12.00%	15.67%	16.90%	14.42%	17.07%	14.22%	12.31%	10.40%	16.25%
Short-Term Debt to Total Capital	5.45%	4.28%	3.05%	3.53%	5.09%	3.64%	7.36%	4.04%	2.94%	0.77%	2.71%
Long-Term Debt to Total Capital	10.82%	10.16%	8.95%	12.14%	11.81%	10.78%	9.71%	10.18%	9.38%	9.63%	13.54%
Preferred Equity to Total Capital	6.93%	6.51%	5.88%	4.84%	4.70%	4.13%	3.87%	3.90%	3.63%	3.83%	3.69%
Noncontrolling Interests to Total Capital	38.60%	39.35%	42.01%	36.60%	35.51%	33.57%	32.46%	32.91%	33.23%	35.62%	32.88%
Common Equity to Total Capital	38.20%	39.70%	40.11%	42.90%	42.89%	47.89%	46.60%	48.97%	50.82%	50.15%	47.18%
Debt to EBITDA	-0.90	-1.34	45.03	3.72	1.21	0.88	1.19	0.86	0.54	0.63	1.30
Net Debt to EBITDA	-0.28	-0.38	13.73	2.28	0.67	0.25	0.61	0.35	0.20	0.11	0.66
Long-Term Debt to EBITDA	-0.60	-0.94	33.57	2.88	0.85	0.66	0.68	0.62	0.41	0.58	1.09
Debt to NOPAT	-1.29	-1.95	19.63	3.38	1.16	0.72	0.97	0.73	0.51	0.69	1.43
Net Debt to NOPAT	-0.41	-0.55	5.99	2.07	0.64	0.21	0.50	0.30	0.20	0.12	0.72
Long-Term Debt to NOPAT	-0.85	-1.37	14.64	2.62	0.81	0.54	0.55	0.52	0.39	0.64	1.19
Noncontrolling Interest Sharing Ratio	47.41%	47.85%	50.80%	49.76%	50.82%	47.75%	48.16%	45.66%	44.72%	44.03%	43.73%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	417	1,686	245	-3,356	-4,712	-4,663	-6,031	-3,015	-3,068	-1,471	-991
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	34.45	136.12	20.16	0.00	0.00	-76.38	-261.05	0.00	0.00	-20.82	-36.58
Operating Cash Flow to Interest Expense	49.69	59.21	35.91	0.00	0.00	8.40	29.58	0.00	0.00	11.02	5.82
Operating Cash Flow Less CapEx to Interest Expense	49.69	59.21	35.91	0.00	0.00	8.40	29.58	0.00	0.00	11.02	5.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.12	0.14	0.17	0.19	0.21	0.21	0.21	0.22	0.27	0.23	0.24
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,817	11,525	12,753	15,509	15,945	18,176	19,403	19,253	20,646	19,589	20,344
Invested Capital Turnover	0.35	0.42	0.51	0.54	0.59	0.61	0.59	0.60	0.69	0.61	0.63
Increase / (Decrease) in Invested Capital	-1,247	-992	596	3,731	5,129	6,651	6,650	3,744	4,701	1,413	941
Enterprise Value (EV)	11,535	13,693	15,253	16,048	17,972	17,559	20,759	20,016	22,788	21,012	20,933
Market Capitalization	6,055	7,938	8,678	8,135	10,061	9,966	12,006	11,819	14,207	12,923	11,820
Book Value per Share	$94.54	$104.69	$117.01	$151.44	$133.61	$170.11	$171.01	$178.31	$201.18	$189.14	$194.89
Tangible Book Value per Share	$89.07	$99.25	$111.60	$146.08	$129.05	$154.96	$156.66	$164.36	$187.42	$175.59	$180.96
Total Capital	10,817	11,525	12,753	15,509	15,945	18,176	19,403	19,253	20,646	19,589	20,344
Total Debt	1,760	1,664	1,530	2,430	2,694	2,620	3,312	2,739	2,543	2,037	3,306
Total Long-Term Debt	1,170	1,170	1,141	1,882	1,883	1,959	1,884	1,960	1,936	1,887	2,754
Net Debt	556	470	467	1,486	1,499	743	1,706	1,111	970	361	1,673
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Nonoperating Expense (NNE)	359	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-39	-24
Net Nonoperating Obligations (NNO)	1,760	1,664	1,530	2,430	2,694	2,620	3,312	2,739	2,543	2,037	3,306
Total Depreciation and Amortization (D&A)	-11	-26	-33	-40	-48	-14	16	9.96	226	6.85	3.74
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($19.27)	$10.40	$12.95	$4.10	$3.81	$31.54	$6.96	$9.44	$22.68	($3.77)	$3.29
Adjusted Weighted Average Basic Shares Outstanding	43.70M	43.72M	43.93M	51.18M	51.17M	52.69M	52.88M	52.16M	51.94M	49.25M	48.65M
Adjusted Diluted Earnings per Share	($19.27)	$10.40	$12.91	$4.09	$3.80	$31.47	$6.94	$9.41	$22.62	($3.76)	$3.27
Adjusted Weighted Average Diluted Shares Outstanding	43.70M	43.72M	43.93M	51.18M	51.17M	52.69M	52.88M	52.16M	51.94M	49.25M	48.65M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	43.70M	43.72M	43.93M	51.18M	51.17M	52.69M	52.88M	52.16M	51.94M	49.25M	48.65M
Normalized Net Operating Profit after Tax (NOPAT)	-785	764	915	454	497	1,098	722	571	1,751	52	21
Normalized NOPAT Margin	-61.60%	37.88%	41.73%	24.50%	27.10%	34.54%	28.03%	20.19%	44.05%	2.33%	0.60%
Pre Tax Income Margin	-93.07%	34.62%	39.64%	20.54%	23.19%	45.12%	24.60%	25.02%	43.65%	-3.74%	-2.06%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-98.02	56.42	71.63	0.00	0.00	23.50	27.43	0.00	0.00	-1.18	-2.61
NOPAT to Interest Expense	-68.61	55.99	69.25	0.00	0.00	32.57	26.77	0.00	0.00	-0.82	-1.83
EBIT Less CapEx to Interest Expense	-98.02	56.42	71.63	0.00	0.00	23.50	27.43	0.00	0.00	-1.18	-2.61
NOPAT Less CapEx to Interest Expense	-68.61	55.99	69.25	0.00	0.00	32.57	26.77	0.00	0.00	-0.82	-1.83
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-6.37%	-8.63%	128.86%	14.39%	4.59%	3.05%	3.36%	3.08%	2.34%	3.93%	4.97%
Augmented Payout Ratio	-37.67%	-23.00%	128.86%	17.91%	4.59%	3.05%	3.36%	5.97%	6.67%	26.45%	49.20%

Key Financial Trends

RenaissanceRe (NYSE: RNR) has shown considerable fluctuations in its financial performance over the last four years, spanning Q3 2022 through Q1 2025. Below is a summary of key trends observed in their recent financial data:

The company consistently earns significant premiums, with premiums earned rising from approximately $1.77 billion in Q2 2023 to $2.72 billion as of Q1 2025, indicating growth in its underwriting operations.
Net realized and unrealized capital gains on investments showed substantial variability but have been largely positive; notably, Q1 2025 recorded a very strong $749 million gain compared to mixed results in prior quarters, supporting non-interest income.
Net income attributable to common shareholders has fluctuated but showed recovery in recent periods, with $161 million in Q1 2025 after losses in Q4 2024, indicating possible stabilization.
Cash and equivalents have grown modestly, reaching about $1.63 billion in Q1 2025 from $1.06 billion in Q1 2023, supporting liquidity.
Total assets increased from roughly $36 billion in Q3 2022 to $53.6 billion in Q1 2025, representing asset growth which may support future revenue generation.

The company’s net interest expense remains negative and represents a regular cost, for example, about $27 million in Q1 2025, reflecting borrowing costs related to long-term debt.
RenaissanceRe regularly pays dividends to common shareholders, around $0.38-0.40 per share consistently, which is attractive for income-focused investors but also a cash outflow.
The total shares outstanding have remained generally stable, around 48.6 to 52 million shares, limiting dilution effects on earnings per share.
Operating cash flows have fluctuated but remain positive in recent quarters, such as $158 million in Q1 2025, indicating operational cash generation despite net income volatility.

RenaissanceRe incurred a net loss in Q1 2025 of approximately $25 million, and a larger loss to noncontrolling interests of $195 million, which signals challenges in profitability in the most recent quarter.
Non-interest expenses including amortization and special charges have increased to around $3.51 billion in Q1 2025 from about $1.75 billion in Q4 2023, pressuring profitability.
Property & Liability insurance claims surged to $2.74 billion in Q1 2025, up significantly from prior periods. This indicates increased claim costs which impact underwriting profit margins.
Long-term debt has increased to about $2.75 billion in Q1 2025 compared to $1.14 billion in Q1 2023, raising interest expense and financial leverage.
Net cash from investing activities remains negative with large purchase of investments outpacing sales, reflecting capital deployment but also cash outflows totaling nearly half a billion in Q1 2025.

In summary, RenaissanceRe has demonstrated growth in premiums and invested assets alongside volatile capital gains impacting its income. The company faces increased insurance claims and rising non-interest expenses weighing on recent profitability. However, positive operational cash flow and stable liquidity provide some financial flexibility. Investors should monitor how the company manages claims costs and amortization charges as well as capital gains performance for future earnings stabilization.

09/17/25 10:25 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About RenaissanceRe's Financials

When does RenaissanceRe's financial year end?

According to the most recent income statement we have on file, RenaissanceRe's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has RenaissanceRe's net income changed over the last 9 years?

RenaissanceRe's net income appears to be on an upward trend, with a most recent value of $2.96 billion in 2024, rising from $542.24 million in 2015. The previous period was $3.62 billion in 2023. See RenaissanceRe's forecast for analyst expectations on what’s next for the company.

How has RenaissanceRe's revenue changed over the last 9 years?

Over the last 9 years, RenaissanceRe's total revenue changed from $1.48 billion in 2015 to $11.60 billion in 2024, a change of 684.5%.

How much debt does RenaissanceRe have?

RenaissanceRe's total liabilities were at $33.16 billion at the end of 2024, a 0.9% decrease from 2023, and a 473.9% increase since 2015.

How much cash does RenaissanceRe have?

In the past 9 years, RenaissanceRe's cash and equivalents has ranged from $421.16 million in 2016 to $1.88 billion in 2023, and is currently $1.68 billion as of their latest financial filing in 2024.

How has RenaissanceRe's book value per share changed over the last 9 years?

Over the last 9 years, RenaissanceRe's book value per share changed from 98.80 in 2015 to 189.14 in 2024, a change of 91.4%.

Related Companies

This page (NYSE:RNR) was last updated on 9/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RenaissanceRe (RNR) Financials

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About RenaissanceRe's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RenaissanceRe (RNR) Financials

Annual Income Statements for RenaissanceRe

Quarterly Income Statements for RenaissanceRe

Annual Cash Flow Statements for RenaissanceRe

Quarterly Cash Flow Statements for RenaissanceRe

Annual Balance Sheets for RenaissanceRe

Quarterly Balance Sheets for RenaissanceRe

Annual Metrics And Ratios for RenaissanceRe

Quarterly Metrics And Ratios for RenaissanceRe

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About RenaissanceRe's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools